BDSX Q1 2021 Earnings — Biodesix, Inc. Revenue & Financial Results | Market Cap Arena

BDSXBiodesix, Inc.

$151M

Q1 2021 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$29M+466.4% YoY

Gross Profit

$11M36.9% margin

Operating Income

-$6M-19.3% margin

Net Income

-$7M-24.1% margin

EPS (Diluted)

$-0.26

QoQ Revenue Growth

+6.8%

Cash Flow

Operating Cash Flow

-$11M

Free Cash Flow

-$12M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$115M

Total Liabilities

$79M

Stockholders' Equity

$36M

Cash & Equivalents

$55M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$29M	$5M	+466.4%
Gross Profit	$11M	$4M	+202.9%
Operating Income	-$6M	-$8M	+33.7%
Net Income	-$7M	-$10M	+28.3%

Revenue Segments

Diagnostic Tests

$27M94%

Service

$2M6%